Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin
No abstract listed.
Evidence that antithrombin and the inhibitor of activated Stuart-Prower factor are separate entities
The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma
Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure
Elimination of 125-I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dogs
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor
The separation of alpha-2 macroglobulin into five components with differing electrophoretic and enzyme-binding properties
Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin
Regulation of factor Xa in vitro in human and mouse plasma and in vivo in mouse. Role of the endothelium and plasma proteinase inhibitors
Specificity of inhibitors lacking in alpha antitrypsin deficiency and hereditary angioedema toward human proteolytic enzymes
The antithrombin activity of alpha-1-protease inhibitor: the antitrypsin activity of antithrombin III
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors
Primary structure of the 'bait' region for proteinases in alpha 2-macroglobulin. Nature of the complex
Human alpha-2-macroglobulin, characterization and trypsin binding. Purification methods, trypsin and plasmin complex formation
Alpha 2-macroglobulin-mediated clearance of proteases from the plasma of the American horseshoe crab, Limulus polyphemus.
Alpha1-antitrypsin and alpha2-macroglobulin in newborn infants. II. Relation to the coagulation system
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma
Plasma prothrombin during treatment with Dicumarol. I. Immunochemical determination of its concentration in plasma
Blood Clotting Disorders
Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.